Skip to main content

ORIGINAL RESEARCH article

Front. Microbiol.

Sec. Antimicrobials, Resistance and Chemotherapy

Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1548362

This article is part of the Research Topic Advancing Antimicrobial Strategies: Nucleic Acid and Peptide-Based Approaches View all articles

Comparative evaluation of antimicrobial peptides: Effect on formation, metabolic activity and viability of Klebsiella pneumoniae biofilms

Provisionally accepted
  • 1 Institute of Bacteriology and Mycology, Center for Infectious Diseases, Faculty of Veterinary Medicine, Leipzig University, Leipzig, Germany
  • 2 Institute of Veterinary Anatomy, Histology and Embryology, Faculty of Veterinary Medicine, Leipzig University, Leipzig, Germany
  • 3 Institute of Bioanalytical Chemistry, Faculty of Chemistry and Mineralogy Leipzig University, Leipzig, Germany
  • 4 Center for Biotechnology and Biomedicine, Leipzig University, Leipzig, Germany

The final, formatted version of the article will be published soon.

    Klebsiella pneumoniae (K. pneumoniae) is a major human nosocomial infectious agent and an important veterinary pathogen, frequently resistant to various antibiotics. It causes diseases such as pneumonia, urinary tract infections, surgical wound infections and septicemia. Biofilm formation of K. pneumoniae promotes persistent infection and contributes to resistance against antimicrobial agents. The objective of this study was to comparatively evaluate the effect of selected AMPs on the formation, metabolic activity and viability of Klebsiella pneumoniae biofilms of veterinary and human origin. Biofilm formation of three K. pneumoniae strains of human and veterinary origin was quantified using the crystal violet assay and visualized by scanning electron microscopy (SEM). The inhibitory effects of eight different AMPs on the formation and metabolic activity of K. pneumoniae biofilms, as well as on planktonic growth, were examined using crystal violet, resazurin and broth microdilution assays, respectively. The effect on living and dead bacteria in mature biofilms was investigated using the fluorescent dyes SYTO™ 9 and propidium iodide. In addition, the distribution of rhodamine B-labeled peptide DJK-5 in mature biofilms of strain 17349 was visualized by confocal laser scanning microscopy (CLSM). Biofilm formation was confirmed for all three K. pneumoniae strains. Depending on the strain, we found that planktonic growth was affected by the AMPs DJK-5, DJK-6, Onc72 and Onc112. Biofilm formation of all three strains was inhibited by hbD3, LL-37, DJK-5 and DJK-6, with biofilm mass reduced to less than 40% of the untreated control. In addition to the inhibition of biofilm formation, a reduction in the metabolic activity of the biofilm-associated bacteria was also observed. These four AMPs also showed an effect on mature biofilms by reducing the number of both viable and dead bacteria in 22 hours-old biofilms. Rhodamine B-labeled DJK-5 took seven hours to visibly accumulate in the planktonic bacteria. Multi-layered biofilm aggregations were mainly negative for rhodamine B-labeled DJK-5, even 44 hours after AMP treatment, indicating that certain parts of mature K. pneumoniae biofilms are not accessible for this AMP. In conclusion, we found differences in the effect of AMPs on biofilms including both increases and decreases in biofilm mass and viability.

    Keywords: Klebsiella pneumoniae, Biofilm formation, LL-37, human Beta Defensin 3, proline-rich AMPs, DJK-5

    Received: 19 Dec 2024; Accepted: 19 Mar 2025.

    Copyright: © 2025 Hanstein, Grochow, Mötzing, Fietz, Hoffmann, Baums and Kähl. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Sophie Kähl, Institute of Bacteriology and Mycology, Center for Infectious Diseases, Faculty of Veterinary Medicine, Leipzig University, Leipzig, Germany

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more